Menarini

Company snapshot

The Menarini Group is an Italian [pharmaceutical](en.wikipedia.org/wiki/Pharmaceutical) company. Its headquarters is in [Florence](en.wikipedia.org/wiki/Florence), [Tuscany](en.wikipedia.org/wiki/Tuscany), and it has three divisions: Menarini Ricerche, Menarini Biotech, and Menarini Diagnostics. It develops pharmacological solutions for [cardiovascular diseases](en.wikipedia.org/wiki/Cardiovascula

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Menarini. Not investment advice.

• What is Menarini?

  Menarini Group is a pharma organization headquartered in CN. Primary therapeutic focus areas include Acute Pain. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipel

• Is Menarini publicly traded?

  Menarini appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Menarini develop or market?

  We link 1 drug profile(s) where Menarini is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/menarini-international-operations-luxembourg-s-a#company-drugs.

• What are the latest developments for Menarini?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Menarini focus on?

  Menarini focuses on Acute Pain based on our analysis of their pipeline programs and drug development activities.